• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们都知道什么是治疗抵抗性抑郁症——不是吗?

We all know what we mean by treatment-resistant depression - don't we?

机构信息

Neuroscience and Psychiatry Unit,Division of Neuroscience and Experimental Psychology,University of Manchester and Manchester Academic Health Science Centre,Manchester M13 9PT,UK.

出版信息

Br J Psychiatry. 2018 May;212(5):259-261. doi: 10.1192/bjp.2018.56.

DOI:10.1192/bjp.2018.56
PMID:29693539
Abstract

Although in common use, treatment-resistant depression is unhelpful both conceptually and practically. In this issue a new term, multiple-therapy-resistant major depressive disorder, is proposed; although it may be useful in guiding treatment options for patients with persisting depression, it should not be an automatic trigger for further, more invasive treatments.Declaration of interestsI.M.A. has been a consultant for pharmaceutical companies developing and marketing antidepressants and has been an author on publications that have used the term treatment-resistant depression.

摘要

虽然在临床上普遍使用,但“治疗抵抗性抑郁症”这个术语无论在概念上还是在实践上都没有帮助。本期提出了一个新术语,即“多种疗法抵抗性重度抑郁症”;虽然它可能有助于指导持续性抑郁症患者的治疗选择,但不应成为进一步更具侵入性治疗的自动触发因素。利益声明 I.M.A. 曾为开发和销售抗抑郁药的制药公司担任顾问,并曾参与使用“治疗抵抗性抑郁症”这一术语的出版物的撰写。

相似文献

1
We all know what we mean by treatment-resistant depression - don't we?我们都知道什么是治疗抵抗性抑郁症——不是吗?
Br J Psychiatry. 2018 May;212(5):259-261. doi: 10.1192/bjp.2018.56.
2
Improving the care of patients who have treatment-resistant depression: the promise of the PCORnet Mood Network.改善治疗抵抗性抑郁症患者的护理:PCORnet 情绪网络的承诺。
J Clin Psychiatry. 2015 Apr;76(4):e528-30. doi: 10.4088/JCP.14com09570.
3
Minocycline as an adjunct for treatment-resistant depressive symptoms: A pilot randomised placebo-controlled trial.米诺环素辅助治疗抵抗性抑郁症状:一项先导随机安慰剂对照试验。
J Psychopharmacol. 2017 Sep;31(9):1166-1175. doi: 10.1177/0269881117724352. Epub 2017 Aug 31.
4
Challenges of Treatment-resistant Depression.难治性抑郁症的挑战
Psychiatr Danub. 2018 Sep;30(3):273-284. doi: 10.24869/psyd.2018.273.
5
Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study.中国伴有焦虑与不伴焦虑的治疗抵抗性抑郁症患者缓解率的差异:OPERATION 研究报告。
J Affect Disord. 2013 Sep 25;150(3):834-9. doi: 10.1016/j.jad.2013.03.012. Epub 2013 Apr 6.
6
Association between antidepressant resistance in unipolar depression and subsequent bipolar disorder: cohort study.单相抑郁的抗抑郁药抵抗与随后的双相障碍之间的关联:队列研究。
Br J Psychiatry. 2012 Jan;200(1):45-51. doi: 10.1192/bjp.bp.110.086983. Epub 2011 Oct 20.
7
Attention-deficit hyperactivity disorder comorbidity and antidepressant resistance among patients with major depression: A nationwide longitudinal study.重度抑郁症患者的注意缺陷多动障碍共病与抗抑郁药耐药性:一项全国性纵向研究。
Eur Neuropsychopharmacol. 2016 Nov;26(11):1760-1767. doi: 10.1016/j.euroneuro.2016.09.369. Epub 2016 Sep 22.
8
Efficacy and safety of adjunctive brexpiprazole 2 mg in major depressive disorder: a phase 3, randomized, placebo-controlled study in patients with inadequate response to antidepressants.辅助使用2毫克布雷哌唑治疗重度抑郁症的疗效和安全性:一项针对对抗抑郁药反应不足患者的3期随机安慰剂对照研究。
J Clin Psychiatry. 2015 Sep;76(9):1224-31. doi: 10.4088/JCP.14m09688.
9
KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE.氯胺酮用于难治性单相和双相重度抑郁症:批判性综述及对临床实践的启示
Depress Anxiety. 2016 Aug;33(8):698-710. doi: 10.1002/da.22505. Epub 2016 Apr 6.
10
Treating depression with adjunctive antipsychotics.用辅助性抗精神病药治疗抑郁症。
Bipolar Disord. 2018 Nov;20 Suppl 2:17-24. doi: 10.1111/bdi.12701.

引用本文的文献

1
The Failed Concept of Treatment Resistance.治疗抵抗的失败概念
Psychiatr Res Clin Pract. 2024 Jun 21;6(3):112-114. doi: 10.1176/appi.prcp.20240073. eCollection 2024 Fall.
2
Biological correlates of treatment resistant depression: a review of peripheral biomarkers.难治性抑郁症的生物学关联:外周生物标志物综述
Front Psychiatry. 2023 Oct 24;14:1291176. doi: 10.3389/fpsyt.2023.1291176. eCollection 2023.
3
Setting national research priorities for difficult-to-treat depression in the UK between 2021-2026.制定英国 2021-2026 年期间治疗难度大的抑郁症的国家研究重点。
J Glob Health. 2022 Dec 22;12:09004. doi: 10.7189/jogh.12.09004.
4
Predicting treatment outcome in depression: an introduction into current concepts and challenges.预测抑郁症的治疗效果:当前概念与挑战简介。
Eur Arch Psychiatry Clin Neurosci. 2023 Feb;273(1):113-127. doi: 10.1007/s00406-022-01418-4. Epub 2022 May 19.
5
Use of 30-Hz Accelerated iTBS in Drug-Resistant Unipolar and Bipolar Depression in a Public Healthcare Setting: A Case Series.在公共医疗环境中,30赫兹加速间歇性θ波重复刺激(iTBS)用于治疗耐药性单相和双相抑郁症:病例系列
Front Psychiatry. 2022 Jan 12;12:798847. doi: 10.3389/fpsyt.2021.798847. eCollection 2021.
6
Experimental Therapeutics in Treatment-Resistant Major Depressive Disorder.难治性重度抑郁症的实验性治疗
J Exp Pharmacol. 2021 Feb 24;13:181-196. doi: 10.2147/JEP.S259302. eCollection 2021.
7
Human induced pluripotent stem cells technology in treatment resistant depression: novel strategies and opportunities to unravel ketamine's fast-acting antidepressant mechanisms.人类诱导多能干细胞技术在难治性抑郁症治疗中的应用:揭示氯胺酮快速抗抑郁机制的新策略与机遇
Ther Adv Psychopharmacol. 2020 Nov 2;10:2045125320968331. doi: 10.1177/2045125320968331. eCollection 2020.
8
Effects of ketamine treatment on suicidal ideation: a qualitative study of patients' accounts following treatment for depression in a UK ketamine clinic.氯胺酮治疗对自杀意念的影响:英国氯胺酮诊所治疗抑郁症后患者报告的定性研究。
BMJ Open. 2019 Aug 15;9(8):e029108. doi: 10.1136/bmjopen-2019-029108.